175 related articles for article (PubMed ID: 31657061)
1. Bioassay of ferulic acid derivatives as influenza neuraminidase inhibitors.
Cui MY; Xiao MW; Xu LJ; Chen Y; Liu AL; Ye J; Hu AX
Arch Pharm (Weinheim); 2020 Jan; 353(1):e1900174. PubMed ID: 31657061
[TBL] [Abstract][Full Text] [Related]
2. Potential New H1N1 Neuraminidase Inhibitors from Ferulic Acid and Vanillin: Molecular Modelling, Synthesis and in Vitro Assay.
Hariono M; Abdullah N; Damodaran KV; Kamarulzaman EE; Mohamed N; Hassan SS; Shamsuddin S; Wahab HA
Sci Rep; 2016 Dec; 6():38692. PubMed ID: 27995961
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and bioassay of 4-thiazolinone derivatives as influenza neuraminidase inhibitors.
Xiao M; Xu L; Lin D; Lian W; Cui M; Zhang M; Yan X; Li S; Zhao J; Ye J; Liu A; Hu A
Eur J Med Chem; 2021 Mar; 213():113161. PubMed ID: 33540229
[TBL] [Abstract][Full Text] [Related]
4. Design and one-pot synthesis of 2-thiazolylhydrazone derivatives as influenza neuraminidase inhibitors.
Yuan K; Xiao M; Tan Y; Ye J; Xie Y; Sun X; Hu A; Lian W; Liu A
Mol Divers; 2017 Aug; 21(3):565-576. PubMed ID: 28536876
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of 4-alkyl-2-amino(acetamino)-6-aryl-1,3-thiazine derivatives as influenza neuraminidase inhibitors.
Li W; Xia L; Hu A; Liu A; Peng J; Tan W
Arch Pharm (Weinheim); 2013 Sep; 346(9):635-44. PubMed ID: 23926081
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of acylguanidine zanamivir derivatives as neuraminidase inhibitors and the evaluation of their bio-activities.
Lin CH; Chang TC; Das A; Fang MY; Hung HC; Hsu KC; Yang JM; von Itzstein M; Mong KK; Hsu TA; Lin CC
Org Biomol Chem; 2013 Jun; 11(24):3943-8. PubMed ID: 23695381
[TBL] [Abstract][Full Text] [Related]
7. Oseltamivir hydroxamate and acyl sulfonamide derivatives as influenza neuraminidase inhibitors.
Hong BT; Chen CL; Fang JM; Tsai KC; Wang SY; Huang WI; Cheng YE; Wong CH
Bioorg Med Chem; 2014 Dec; 22(23):6647-6654. PubMed ID: 25456388
[TBL] [Abstract][Full Text] [Related]
8. 3D-quantitative structure-activity relationship and antiviral effects of curcumin derivatives as potent inhibitors of influenza H1N1 neuraminidase.
Lai Y; Yan Y; Liao S; Li Y; Ye Y; Liu N; Zhao F; Xu P
Arch Pharm Res; 2020 May; 43(5):489-502. PubMed ID: 32248350
[TBL] [Abstract][Full Text] [Related]
9. Further discovery of caffeic acid derivatives as novel influenza neuraminidase inhibitors.
Xie Y; Huang B; Yu K; Xu W
Bioorg Med Chem; 2013 Dec; 21(24):7715-23. PubMed ID: 24262883
[TBL] [Abstract][Full Text] [Related]
10. 3D QSAR and docking study of flavone derivatives as potent inhibitors of influenza H1N1 virus neuraminidase.
Gao L; Zu M; Wu S; Liu AL; Du GH
Bioorg Med Chem Lett; 2011 Oct; 21(19):5964-70. PubMed ID: 21843936
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of NH
Wang K; Yang F; Wang L; Liu K; Sun L; Lin B; Hu Y; Wang B; Cheng M; Tian Y
Eur J Med Chem; 2017 Dec; 141():648-656. PubMed ID: 29107426
[TBL] [Abstract][Full Text] [Related]
12. Discovery of acylguanidine oseltamivir carboxylate derivatives as potent neuraminidase inhibitors.
Li Z; Meng Y; Xu S; Shen W; Meng Z; Wang Z; Ding G; Huang W; Xiao W; Xu J
Bioorg Med Chem; 2017 May; 25(10):2772-2781. PubMed ID: 28385598
[TBL] [Abstract][Full Text] [Related]
13. Discovery of (E)-1-amino-4-phenylbut-3-en-2-ol derivatives as novel neuraminidase inhibitors.
Lu C; Yin Y; Meng F; Dun Y; Pei K; Wang C; Xu X; Wu F
Bioorg Med Chem Lett; 2018 Jun; 28(11):2003-2007. PubMed ID: 29748050
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the anti-neuraminidase activity of the traditional Chinese medicines and determination of the anti-influenza A virus effects of the neuraminidase inhibitory TCMs in vitro and in vivo.
Tian L; Wang Z; Wu H; Wang S; Wang Y; Wang Y; Xu J; Wang L; Qi F; Fang M; Yu D; Fang X
J Ethnopharmacol; 2011 Sep; 137(1):534-42. PubMed ID: 21699971
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and biological activity of thiazole derivatives as novel influenza neuraminidase inhibitors.
Liu Y; Zhang L; Gong J; Fang H; Liu A; Du G; Xu W
J Enzyme Inhib Med Chem; 2011 Aug; 26(4):506-13. PubMed ID: 21143042
[TBL] [Abstract][Full Text] [Related]
16. Novel N-Substituted oseltamivir derivatives as potent influenza neuraminidase inhibitors: Design, synthesis, biological evaluation, ADME prediction and molecular docking studies.
Ye J; Yang X; Xu M; Chan PK; Ma C
Eur J Med Chem; 2019 Nov; 182():111635. PubMed ID: 31493744
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological evaluation of novel zanamivir derivatives as potent neuraminidase inhibitors.
Cheng LP; Wang TC; Yu R; Li M; Huang JW
Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3622-3629. PubMed ID: 30389293
[TBL] [Abstract][Full Text] [Related]
18. In vitro antiviral effects and 3D QSAR study of resveratrol derivatives as potent inhibitors of influenza H1N1 neuraminidase.
Li C; Fang JS; Lian WW; Pang XC; Liu AL; Du GH
Chem Biol Drug Des; 2015 Apr; 85(4):427-38. PubMed ID: 25185493
[TBL] [Abstract][Full Text] [Related]
19. Discovery of novel "Dual-site" binding oseltamivir derivatives as potent influenza virus neuraminidase inhibitors.
Ai W; Zhang J; Zalloum WA; Jia R; Cherukupalli S; Ding X; Sun Z; Sun L; Jiang X; Ma X; Li Z; Wang D; Huang B; Zhan P; Liu X
Eur J Med Chem; 2020 Apr; 191():112147. PubMed ID: 32092589
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and biological evaluation of novel 1, 3, 4-oxadiazole derivatives as potent neuraminidase inhibitors.
Yu W; Ping Cheng L; Pang W; Ling Guo L
Bioorg Med Chem; 2022 Mar; 57():116647. PubMed ID: 35121400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
